Results 211 to 220 of about 96,828 (293)

Eosinophilic cholangitis misdiagnosed as cholangiocarcinoma: a case report. [PDF]

Front Oncol
Hou Y, Wang X, Chang J, Yang X.
europepmc   +1 more source

Gene Expression Levels of Ferroptosis Suppressor Protein (FSP1) and Ferroptosis Inducer (ACSL4) and Their Correlation With Clinicopathological Features in Colorectal Cancer Patients

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aim Ferroptosis signaling pathway has been revealed to play a biological role in the tumorigenesis of colorectal cancer (CRC). Our aim was to evaluate the expression pattern and clinical potentials of two ferroptosis‐related genes FSP1 and ACSL4 in colorectal tumors.
Afsaneh Fardsanei, Mohammad Taghi Goodarzi, Shahram Agah, Jafar Izadinia, Abolfazl Akbari   +4 more
wiley   +1 more source

An Unusual Presentation of Cholangiocarcinoma: The Sister Mary Joseph Nodule-A Case Report. [PDF]

Reports (MDPI)
Esposito T, Singh N, Sheth R, Keckeisen G.   +3 more
europepmc   +1 more source

Peripheral Blood Biomarkers Predict Outcomes in Advanced Cancers Treated With Anti‐PD‐1 Therapy

Immunity, Inflammation and Disease, Volume 14, Issue 5, May 2026.
This study identifies dNLR≤ 3.18, AMC ≤ 0.48, IL‐6 ≤ 12.35, and squamous histology as independent predictors of improved survival in advanced cancers treated with anti‐PD‐1 therapy. A novel biomarker‐based model demonstrates high accuracy for 1‐year survival stratification, aiding clinical decision‐making.
Chunxia Feng, Ping Li, Qianhui Gu, Minbin Chen, Jinhua Gu   +4 more
wiley   +1 more source

Metachronous Pheochromocytoma and Cholangiocarcinoma in a patient with Neurofibromatosis type 1: a case report. [PDF]

Oxf Med Case Reports
Al Harrak Y, Lkhoyaali S, Lamsyah O, Boutayeb S, El Ghissassi I, M'rabti H, Errihani H.   +6 more
europepmc   +1 more source

Epidemiology, Risk Factors and Pathophysiology of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: An Update

JCC Plus, Volume 1, Issue 3, May 2026.
ABSTRACT Background and Aims Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) represent a unique clinical syndrome affecting up to 80% of PSC patients, characterised by distinct epidemiological patterns, pathophysiological mechanisms and clinical outcomes that differ substantially from either condition occurring independently ...
Luisa Bertin, Paul Henderson, Richard Pollok, Natália Queiroz, Luca Fabris, Edoardo Vincenzo Savarino, Iago Rodríguez‐Lago, Brigida Barberio   +7 more
wiley   +1 more source

Prognostic value of cGAS-STING-IRF3 signaling in cholangiocarcinoma patients. [PDF]

PLoS One
Artbua P, Kentachalee N, Sitthirak S, Sa-Ngiamwibool P, Wichian P, Deenonpoe R.   +5 more
europepmc   +1 more source

Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine

The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 5, May 2026.
ABSTRACT This trial was to evaluate the efficacy and the safety of colchicine for the palliative treatment of patients with primary hepatic malignancy unable to receive curative treatment. Forty hepatocellular carcinoma (HCC) patients and two intrahepatic cholangiocarcinoma (ICC) patients signed the informed consents.
Zu‐Yau Lin, Ming‐Lun Yeh, Po‐Cheng Liang, Shinn‐Cherng Chen, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Ming‐Lung Yu, Wan‐Long Chuang   +8 more
wiley   +1 more source

Whole‐Genome Bisulfite Sequencing Identifies Blood‐Based DNA Methylation Biomarker for Hepatocellular Carcinoma

Molecular Carcinogenesis, Volume 65, Issue 5, Page 603-614, May 2026.
ABSTRACT Functional DNA methylation abnormalities are a hallmark of human cancers and may be a promising biomarker for their early diagnosis. Moreover, the largest methylation differences can improve the sensitivity of noninvasive diagnoses of solid tumors.
Junsheng Zhao, Sijia Shen, Junjie Zhang, Ying Xu, Jing Peng, Hainv Gao, Lanjuan Li   +6 more
wiley   +1 more source